UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NYSE: UCB) | Delayed: 37.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.04 | 52 Week High | $ | |||
| Open | $37.04 | 52 Week Low | $ | |||
| Day High | $37.04 | P/E | N/A | |||
| Day Low | $37.04 | EPS | $ | |||
| Volume | 2,427 | |||||
| UCB Unsponsored ADR (AMEX: UCBJY) | Delayed: 153.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $153.95 | 52 Week High | $46.25 | |||
| Open | $153.95 | 52 Week Low | $32.74 | |||
| Day High | $153.95 | P/E | N/A | |||
| Day Low | $153.95 | EPS | $0.00 | |||
| Volume | 7 | |||||
